Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance.
about
Pharmaceutical policies: effects of cap and co-payment on rational use of medicinesPharmaceutical policies: effects of cap and co-payment on rational drug useAssessing barriers to health insurance and threats to equity in comparative perspective: the Health Insurance Access Database.How patient cost-sharing trends affect adherence and outcomes: a literature review.Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid populationWhat impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.Potential bias in medication adherence studies of prevalent users.Effect of cost-sharing on use of asthma medication in children.Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma.How does copayment for health care services affect demand, health and redistribution? A systematic review of the empirical evidence from 1990 to 2011.Impact of Copayment Changes on Children's Albuterol Inhaler Use and Costs after the Clean Air Act Chlorofluorocarbon Ban.Evaluating the effects of Quebec's private-public drug insurance system.Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia.The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain.Applying a health system perspective to the evolving Farmácia Popular medicines access programme in Brazil.
P2860
Q24188009-08571927-C727-41E2-A106-3844D865146CQ24242490-F301752B-F94F-43D3-B516-CB7A2C66671BQ31060705-295B60A2-9C57-4D93-9E87-20604423A91BQ35752951-DD14DC39-D732-400D-A0E1-326B42B69227Q36332023-04D3E57C-FD0A-4912-BABE-4242F586743DQ36699426-5910E892-5344-425C-9AD1-7E5F6721C2C8Q37050974-FE33B5F1-55BE-4906-AE82-8D700941DC49Q37077190-1E9F6E6F-204E-40FC-8D4F-5237629C1FBBQ37083290-F1F78C66-EB69-482F-B4B8-741F066D9DAFQ38132664-BD04A02F-9D39-4962-AE4E-0E6B154FF55BQ39169672-73390268-4C48-4B3F-98A0-87A73CE1235FQ50091332-28CD91DC-5EF5-4A7F-915C-C99A15C3DB70Q50782186-2B8B11BE-E656-4B96-9841-C0DC3B0E7F01Q51151532-4917EEB4-EBB9-4303-8FD3-BC533A6A39C5Q52661665-2E2369D0-65F7-454F-964F-6C466265AEF3
P2860
Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Impact of a cost sharing drug ...... s receiving social assistance.
@ast
Impact of a cost sharing drug ...... s receiving social assistance.
@en
type
label
Impact of a cost sharing drug ...... s receiving social assistance.
@ast
Impact of a cost sharing drug ...... s receiving social assistance.
@en
prefLabel
Impact of a cost sharing drug ...... s receiving social assistance.
@ast
Impact of a cost sharing drug ...... s receiving social assistance.
@en
P2093
P1433
P1476
Impact of a cost sharing drug ...... s receiving social assistance.
@en
P2093
Elham Rahme
Jacques LeLorier
Julie Couture
Lucie Blais
P304
P356
10.1016/S0168-8510(02)00158-6
P577
2003-05-01T00:00:00Z